¹⁸F-Fluoromisonidazole in tumor hypoxia imaging

Area of Science:

• Oncology
• Medical Imaging
• Radiochemistry

Background:

• Tumor hypoxia is a significant factor influencing cancer progression, resistance to therapies like radiotherapy and chemotherapy, and patient outcomes.
• Accurate assessment of tumor hypoxia is vital for predicting prognosis and guiding clinical treatment strategies.

Purpose of the Study:

• To review the fundamental concepts, detection mechanisms, and methodologies related to tumor hypoxia.
• To explore the utility and advancements of 18F-Fluoromisonidazole positron emission tomography (18F-FMISO PET) in visualizing and quantifying tumor hypoxia.

Main Methods:

• Comprehensive literature review on tumor hypoxia and its detection.
• Focus on 18F-FMISO PET as a key imaging modality.
• Discussion of correlations between 18F-FMISO PET and other hypoxia detection techniques.

Main Results:

• 18F-FMISO PET provides a noninvasive and comprehensive approach for visualizing tumor hypoxia in both clinical and preclinical research.
• The review details the established role of 18F-FMISO PET in assessing tumor hypoxia.
• Exploration of the relationship between 18F-FMISO PET findings and other diagnostic methods.

Conclusions:

• 18F-FMISO PET is a valuable tool for noninvasive tumor hypoxia imaging, impacting prognosis and treatment planning.
• Continued development and application of 18F-FMISO PET are expected to enhance cancer management strategies.
• Understanding tumor hypoxia through advanced imaging like 18F-FMISO PET is critical for improving patient outcomes.